Tandem Diabody
-
- Targets: HER1 & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & HER2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PSCA & CD8
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Betv1 & Feld1
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL17A & TNF
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & OPN
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL-17A & IL-23
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & MET
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & FGF
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL-15 & TNFSF9
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & PDGFRβ
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: HER2 & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IGFR & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcαRI & HLA class II
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: GD2 & FcγRIII
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD20 & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & HER2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL-23 & IL-6
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & ANG2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: AR & DNA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & HER3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL4 & IL13
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD47 & SIRPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Myosin & CD45
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: gpA33 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: DKKl & SOST
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD22 & CD19
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD20 & CD22
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD19 & CD47
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: NG2 & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Ang2 & VEGFA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGF & VEGF-B
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD33 & FcγRIII
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EPCAM & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: VEGFR2 & VEGFR3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Melanoma-associated proteoglycan & CD28
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PDGFR2 & VEGFR2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PLAP & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRIII & CD30
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: EGFR & IGFR
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRIIB & LPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FcγRI & LPA
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: TCR(Vβ 8 ) & M2
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD28 & melanoma-associated proteoglycan
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: S protein & pre S2 protein
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: Thyroglobulin & TPO
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FOLR1 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: FN1 & HSG
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: TROP-2 & HSG
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CEA & Ad fiber knob
- Type: Tandem Diabody
- Application: FuncS, Gene delivery in gene therapy
Compare
-
- Targets: CD40 & Ad fiber knob
- Type: Tandem Diabody
- Application: FuncS, Gene delivery in gene therapy
Compare
-
- Targets: C5 & HRPO
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare
-
- Targets: EGFR & ZnO
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare
-
- Targets: phenyloxazolone(phOx) & hen egg lysosome(HEL)
- Type: Tandem Diabody
- Application: FuncS, Immunoassay
Compare
-
- Targets: CD19 & CD3
- Type: Tandem Diabody
Compare
-
- Targets: CD30 & CD16A
- Type: Tandem Diabody
Compare
-
- Targets: CD22 & CD79b
- Type: Tandem Diabody
- Application: FC
Compare
-
- Targets: CD33 & CD3
- Type: Tandem Diabody
- Application: FC
Compare
-
- Targets: CD33 & CD3
- Type: Tandem Diabody
- Application: FC
Compare
-
- Targets: EGFRvIII & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: GPC3 & CD3
- Type: DAF
- Application: FC, ELISA
Compare
-
- Targets: IL23R & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: IL5R & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: PROM1 & CD3
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: CD45 & CD79
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: MET & EpCAM
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
Compare
-
- Targets: MET & VEGFR-2
- Type: scFv2-Fc
- Application: FC
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV
- Epitope: HPVGDADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
-
- Species Reactivity: EBV4
- Epitope: HPVGEADYFEY
- MHC: HLA-B*35:01
Compare
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.